Click for article
No blood pressure lowering agents used either alone or in combination prolong survival in adults with diabetes and kidney disease, a meta-analysis published in the Lancet has found.
Researchers analysed 157 studies comparing blood pressure lowering agents in a total of 43 256 patients with diabetic kidney disease, mostly type 2 diabetes and chronic kidney disease
Advertisements
0 Responses to “No blood pressure lowering agents prolong survival in diabetes and kidney disease, review shows”